CoChat
Sign Up
Cited by 6

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Multi-dimensional modeling of nanoparticles transportation from capillary bed into the tumor microenvironment

Jafari-Matanagh, Sina, Razavi, Seyed Esmail, Ehghaghi Bonab, Mir Biuk, Omidian, Hossein, Omidi, Yadollah·2023·Computers in Biology and Medicine
DOI 10.1016/j.compbiomed.2022.106477
Open this paper in CoChat — free account

Abstract

In this study, we examined the extravasation of pharmaceutical inorganic nanoparticles (NPs) with a new approach from the leaky endothelium of tumor microvasculature (TMV) into the tumor microenvironment (TME) multi-dimensionally. We proposed a combination of prevailing macroscopic and microscopic methods and addressed the effect of interstitial fluid (IF) retention in solid tumor as an imperative parameter in drug delivery modeling. The Navier-Stokes equations and Darcy's law were utilized for blood flow and porous media, and the Starling's law was brought in for coupling effect. The blood flow was simulated as a non-Newtonian fluid alongside the Newtonian IF. We applied the Galerkin finite element method for the simulations. Our parametric study includes examining the effect of IF retention and TMV pressure on the distribution of tumor interstitial fluid pressure (TIFP), NPs concentration, and diameter on the penetration process, together with the time effect, on two-dimensional (2D) delivery of NPs. Our findings indicate that the IF retention in tumor cells increases TIFP depending on the amount of TMV pressure and IF retained. In addition to doubling pressure in the tumor necrotic region rather than the rest of TME, it enhances the TIFP which is an important parameter in drug delivery to solid tumors. By decreasing pressure drop within the TMV, pressure distribution within the TME becomes more uniform, creating a better condition for homogeneous penetration of NPs. Increa…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.compbiomed.2022.106477

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 2 references

Research works printed but not linked: 42

  1. Siegel, 2022, Cancer statistics, 2022, CA, Cancer J. Clin., 72, 7, 10.3322/caac.21708 · DOI · Paper page
  2. Omidi, 2014, Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines, Bioimpacts, 4, 55
  3. De Palma, 2017, Microenvironmental regulation of tumour angiogenesis, Nat. Rev. Cancer, 17, 457, 10.1038/nrc.2017.51 · DOI · Paper page
  4. Barar, 2013, Dysregulated pH in tumor microenvironment checkmates cancer therapy, Bioimpacts, 3, 149
  5. Grivennikov, 2010, Immunity, inflammation, and cancer, Cell, 140, 883, 10.1016/j.cell.2010.01.025 · DOI · Paper page
  6. Miller, 2022, Cancer treatment and survivorship statistics, 2022, CA, Cancer J. Clin., 72, 409, 10.3322/caac.21731 · DOI
  7. Lee, 2020, Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity, Exp. Mol. Med., 52, 1475, 10.1038/s12276-020-00500-y · DOI
  8. Kyu Shim, 2022, Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: preclinical evidence for safe and effective drug delivery, Adv. Drug Deliv. Rev., 183, 10.1016/j.addr.2022.114177 · DOI
  9. Shi, 2017, Cancer nanomedicine: progress, challenges and opportunities, Nat. Rev. Cancer, 17, 20, 10.1038/nrc.2016.108 · DOI · Paper page
  10. Tenchov, 2021, Lipid Nanoparticles─From liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement, ACS Nano, 15, 16982, 10.1021/acsnano.1c04996 · DOI · Paper page
  11. Peer, 2007, Nanocarriers as an emerging platform for cancer therapy, Nat. Nanotechnol., 2, 751, 10.1038/nnano.2007.387 · DOI · Paper page
  12. Zheng, 2016, One-pot synthesis of metal–organic frameworks with encapsulated target molecules and their applications for controlled drug delivery, J. Am. Chem. Soc., 138, 962, 10.1021/jacs.5b11720 · DOI
  13. Mohammadi, 2022, Numerical investigation on the anti-angiogenic therapy-induced normalization in solid tumors, Pharmaceutics, 14, 363, 10.3390/pharmaceutics14020363 · DOI
  14. Zhan, 2018, Computational modelling of drug delivery to solid tumour: understanding the interplay between chemotherapeutics and biological system for optimised delivery systems, Adv. Drug Deliv. Rev., 132, 81, 10.1016/j.addr.2018.07.013 · DOI
  15. Mousavi, 2022, Modeling the efficacy of different anti-angiogenic drugs on treatment of solid tumors using 3D computational modeling and machine learning, Comput. Biol. Med., 146, 10.1016/j.compbiomed.2022.105511 · DOI
  16. Liu, 2022, Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer, Nat. Commun., 13, 816, 10.1038/s41467-022-28421-6 · DOI
  17. Baxter, 1989, Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection, Microvasc. Res., 37, 77, 10.1016/0026-2862(89)90074-5 · DOI
  18. Baxter, 1990, Transport of fluid and macromolecules in tumors. II. Role of heterogeneous perfusion and lymphatics, Microvasc. Res., 40, 246, 10.1016/0026-2862(90)90023-K · DOI
  19. Baxter, 1991, Transport of fluid and macromolecules in tumors: III. Role of binding and metabolism, Microvasc. Res., 41, 5, 10.1016/0026-2862(91)90003-T · DOI
  20. Shipley, 2010, Multiscale modelling of fluid and drug transport in vascular tumours, Bull. Math. Biol., 72, 1464, 10.1007/s11538-010-9504-9 · DOI
  21. Soltani, 2011, Numerical modeling of fluid flow in solid tumors, PLoS One, 6, 10.1371/journal.pone.0020344 · DOI
  22. Barar, 2015, Bioimpacts of nanoparticle size: why it matters?, Bioimpacts, 5, 113, 10.15171/bi.2015.23 · DOI
  23. Soltani, 2012, Effect of tumor shape and size on drug delivery to solid tumors, J. Biol. Eng., 6, 4, 10.1186/1754-1611-6-4 · DOI · Paper page
  24. Soltani, 2013, Numerical modeling of interstitial fluid flow coupled with blood flow through a remodeled solid tumor microvascular network, PLoS One, 8, 10.1371/journal.pone.0067025 · DOI
  25. Cattaneo, 2014, A computational model of drug delivery through microcirculation to compare different tumor treatments, Int. J. Numer. Method. Biomed. Eng., 30, 1347, 10.1002/cnm.2661 · DOI
  26. Sefidgar, 2014, Effect of tumor shape, size, and tissue transport properties on drug delivery to solid tumors, J. Biol. Eng., 8, 12, 10.1186/1754-1611-8-12 · DOI · Paper page
  27. Sefidgar, 2015, Numerical modeling of drug delivery in a dynamic solid tumor microvasculature, Microvasc. Res., 99, 43, 10.1016/j.mvr.2015.02.007 · DOI
  28. Wu, 2014, The effect of interstitial pressure on therapeutic agent transport: coupling with the tumor blood and lymphatic vascular systems, J. Theor. Biol., 355, 194, 10.1016/j.jtbi.2014.04.012 · DOI
  29. Nabil, 2015, Modelling mass and heat transfer in nano-based cancer hyperthermia, R. Soc. Open Sci., 2, 10.1098/rsos.150447 · DOI
  30. Moghadam, 2015, Numerical simulation of the tumor interstitial fluid transport: consideration of drug delivery mechanism, Microvasc. Res., 101, 62, 10.1016/j.mvr.2015.06.007 · DOI
  31. Wittenborn, 2016, Simulation of heterogeneous molecular delivery in tumours using μCT reconstructions and MRI validation, Microvasc. Res., 108, 69, 10.1016/j.mvr.2016.08.004 · DOI
  32. Ne’mati, 2017, 119, 461
  33. Chamseddine, 2018, Nanoparticle optimization for enhanced targeted anticancer drug delivery, J. Biomech. Eng., 140, 10.1115/1.4038202 · DOI
  34. Kashkooli, 2020, Drug delivery to solid tumors with heterogeneous microvascular networks: novel insights from image-based numerical modeling, Eur. J. Pharmaceut. Sci., 151
  35. Kara, 2020, Tumor ablation due to inhomogeneous anisotropic diffusion in generic three-dimensional topologies, Phys. Rev., 102
  36. Halabian, 2021, A numerical study on the effect of osmotic pressure on stress and strain in intercellular structures of tumor tissue in the poro-elastic model, Meccanica, 56, 2471, 10.1007/s11012-021-01395-3 · DOI
  37. Ling, 1976, What retains water in living cells?, Science, 191, 293, 10.1126/science.1082166 · DOI
  38. Gilbert, 2019, ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival, Oncogene, 38, 194, 10.1038/s41388-018-0426-6 · DOI
  39. Barisam, 2015, A three-dimensional two phase method for predicting drug delivery to tumor, Powder Technol., 283, 530, 10.1016/j.powtec.2015.06.026 · DOI
  40. Barisam, 2016, The effect of red blood cell motion and deformation on nanoparticle delivery to tumor, Adv. Powder Technol., 27, 1360, 10.1016/j.apt.2016.04.030 · DOI
  41. Rezaeian, 2019, Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy, Drug Deliv., 26, 898, 10.1080/10717544.2019.1660435 · DOI
  42. Zakariapour, 2017, 116, 251

Cited by

Sorted by citations

Metadata

Authors
Jafari-Matanagh, S., Razavi, S. E., Ehghaghi Bonab, M. B., Omidian, H., & Omidi, Y.
Venue
Computers in Biology and Medicine
Publisher
Elsevier BV
Published
2023-01
Volume
152
Pages
106477
ISSN
0010-4825
DOI
10.1016/j.compbiomed.2022.106477
Cited by
6
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review